FDA Draft Guidance Stretches Nanotech “Perhaps Massively” – Trade Group
This article was originally published in The Tan Sheet
Executive Summary
FDA's draft guidance suggesting ingredients up to 1 micrometer in size that exhibit “altered properties” still qualify as nanomaterials should be revised to avoid confusion in the marketplace and promote international harmonization, according to the Personal Care Products Council.